Regenxbio director Gregory Austin Ciongoli acquires common shares worth $952,001.59 - RGNX News | RalliesRegenxbio director Gregory Austin Ciongoli acquires common shares worth $952,001.59
R
RGNX• Director increases stake through open-market buying
- Regenxbio director Gregory Austin Ciongoli lifted his stake to 118,035 common shares, reflecting open-market buying.
- Purchases totaled 102,603 shares at weighted-average prices of USD 9.14 and USD 9.36.
- He also received 15,432 restricted stock units.
- The award included 69,609 stock options with an exercise price of USD 8.91.
•
